<?xml version="1.0" encoding="UTF-8"?>
<ref id="B107" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Merlin</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sato</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nowell</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pakzad</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Fahey</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Gao</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2018</year>). 
  <article-title class="article-title">The PPARγ agonist rosiglitazone promotes the induction of brite adipocytes, increasing β-adrenoceptor-mediated mitochondrial function and glucose uptake.</article-title>
  <source class="source">
   <italic class="italic">Cell. Signal.</italic>
  </source>
  <volume class="volume">42</volume>
  <fpage class="fpage">54</fpage>–
  <lpage class="lpage">66</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.cellsig.2017.09.023</pub-id>
  <?supplied-pmid 28970184?>
  <pub-id pub-id-type="pmid" class="pub-id">28970184</pub-id>
 </mixed-citation>
</ref>
